ミュータントのRASを2倍にすると,MEKや白血病を克服できます
Zuzana Tothova1, Benjamin L Ebert1
1Brigham and Women's Hospital, Division of Hematology, Boston, MA 02115, USA; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Cell
|February 25, 2017
まとめ
研究者は,KRAS変異が急性骨髄性白血病におけるMEK阻害剤に対するがん細胞の成長と反応にどのように影響するか研究した. 彼らは突然変異と正常なKRASのバランスが 治療の有効性を予測し 新しいバイオマーカーを示唆することを発見しました
科学分野:
- 腫瘍学
- 分子生物学
- 癌 の 遺伝
背景:
- RAS経路はがん治療において重要な標的ですが 効果的な標的は依然として課題です
- KRAS変異は,急性骨髄性白血病 (AML) を含む様々な癌の一般的な駆動因子です.
- ミュータント型と野生型KRASの相互作用を理解することは,標的治療の開発に不可欠です.
研究 の 目的:
- 変異型と野生型KRASの相対的な発現がAMLにおけるクローン適性をどのように影響するか調査する.
- KRAS発現レベルがMEK阻害剤に対する感受性に与える影響を決定する.
- AMLにおけるMEK阻害剤療法における予測バイオマーカーとしてのKRAS発現の可能性を評価する.
主な方法:
- KrasG12D ミュータントAMLマウスモデルを使用した.
- 変異型と野生型KRASアレルの相対的な発現を定量化した.
- 異なるKRAS発現シナリオでクローンフィットネスと腫瘍の成長を評価した.
- KRASの変異状態に基づいて,MEK阻害剤治療に対する反応を評価した.
主要な成果:
- 変異したKRASと野生型のKRASの比率は,AMLモデルのクローン適性を有意に調節した.
- 異なるKRAS発現レベルは,MEK阻害剤に対する異なる感受性に相関する.
- 治療反応に関連した特定のKRAS発現プロファイルが特定されました.
結論:
- 変異型と野生型KRASの相対的な発現は,KrasG12D AMLにおけるクローンフィットネスとMEK阻害剤の感受性の重要な決定因子である.
- KRAS発現レベルは,AML患者におけるMEK阻害剤治療の指針として有望である.
- 腫瘍学における信頼性の高いバイオマーカーとしてのKRAS発現を確立するために,さらなる臨床検証が必要である.
関連する概念動画
The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K
Small GTPases - Ras and Rho
5.6K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.6K
MAPK Signaling Cascades
8.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
In-vitro Mutagenesis
17.4K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.4K


